Showing below up to 50 results in range #1 to #50.
- Clinical research regulations in the European Union (1 revision)
- Project:Copyrights (1 revision)
- FDA Form 1572 (2 revisions)
- Documentation (2 revisions)
- Unexpected adverse drug reaction (2 revisions)
- Legally acceptable representative (2 revisions)
- Well-being (2 revisions)
- Estimand (2 revisions)
- Request for Proposal (2 revisions)
- Subject identification code (2 revisions)
- Original medical record (2 revisions)
- Multicentre trial (2 revisions)
- Monitoring report (2 revisions)
- Nonclinical study (2 revisions)
- Source documents (2 revisions)
- Coordinating Committee (3 revisions)
- Bias (3 revisions)
- Investigator's brochure (3 revisions)
- Impartial witness (3 revisions)
- Contract (3 revisions)
- Compassionate use (3 revisions)
- Bioavailability and bioequivalence requirements (3 revisions)
- Safety (3 revisions)
- Phase II clinical trials (3 revisions)
- Monitoring (3 revisions)
- Direct Access (3 revisions)
- Vulnerable subjects (3 revisions)
- Randomization (3 revisions)
- Project:Privacy Policy (3 revisions)
- Approval (3 revisions)
- Serious adverse event (serious adverse drug reaction) (3 revisions)
- Basic experimental studies involving humans (3 revisions)
- Investigational product (3 revisions)
- Opinion (in relation to Independent Ethics Committee) (3 revisions)
- Sponsor-investigator (3 revisions)
- Functional Service Provision (3 revisions)
- Trial site (3 revisions)
- Sub-investigator (3 revisions)
- Controls in clinical trials (3 revisions)
- Comparison of IRB and IEC requirements (4 revisions)
- ALCOA (4 revisions)
- Certified copy (4 revisions)
- Audit Report (4 revisions)
- Plain language summary of study results (4 revisions)
- Amendment (4 revisions)
- Project:About (4 revisions)
- Comparator (4 revisions)
- Corrective and Preventive Action (4 revisions)
- Clinical trial registry (4 revisions)
- Clinical trial (study) report (4 revisions)